Preventative Ovary Removal In Premenopausal Women Should Be Discontinued, Researchers Warn

Preventative Ovary Removal In Premenopausal Women Should Be Discontinued, Researchers Warn
Ovary removal is commonly used in premenopausal women as a preventive measure against the development of ovarian cancer, but researchers now recommend this practice to be discontinued if women are not at high risk. The study, “Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study,” published in the Mayo Clinic Proceedings, shows that ovary removal in young women is associated with higher incidence of several chronic conditions that markedly affect their health. Although a number of studies suggests that the long-term risks of ovary removal before menopause are greater than the benefits, some researchers still argue that in the absence of a randomized clinical trial, the evidence against ovary removal is not sufficient to change the practice. In this study, researchers aimed to address if ovary removal could accelerate the accumulation of multiple chronic diseases, and whether estrogen therapy could modify this accumulation. Researchers analyzed data from 1,653 premenopausal women included in the Rochester Epidemiology Project records-linkage system. All had undergone removal of both ovaries (or bilateral oophorectomy). Each woman was randomly matched to a woman born in the same year, who had not removed her ovaries. After a median follow-up of 14 years, removal of both ovaries in women under 46 years old was found to be associated with a significantly increased risk of developing eight out of 18 chronic health conditions investigated, such as depression, hyperlipidemia (excessive levels of fat in the blood), cardiac arrhythmias, coronary art
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *